Gan & Lee Pharmaceuticals. (603087.SS) SHH
54.87
-0.12(-0.22%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 40.33B |
| Enterprise Value | 38.37B |
| P/E Ratio | 31.51 |
| PEG Ratio | 1.34 |
| Price/Sales Ratio | 8.31 |
| Price/Book Ratio | 2.73 |
| Enterprise/Revenue | 7.77 |
| Enterprise/EBITDA | -306.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.26 |
| Operating Margin | -0.03 |
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 4.05B |
| Revenue/Share | 6.71 |
| Gross Profit | 3.07B |
| EBITDA | 1.07B |
| Net Income | 1.14B |
| Diluted EPS | 1.93 |
Balance Sheet
| Total Cash | 3.42B |
| Total Cash/Share | 5.81 |
| Total Debt | 10.54M |
| Total Debt/Equity | 0 |
| Current Ratio | 7.99 |
| Book Value Per Share | 20.12 |
Price History
| 52-Week Change | -4.07 |
| 52-Week High | 82.25 |
| 52-Week Low | 51.51 |
| Moving Average 50 Days | 59.66 |
| Moving Average 200 Days | 66.13 |
Statistics
| Average Volume | 6.5M |
| Shares Outstanding | 597.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 3.64 |
| Payout Ratio | 0.58 |
| Last Split Factor | 7:5 |
| Last Split Date | August 20, 2020 |
